Cargando…

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment

Detalles Bibliográficos
Autor principal:	Martinez, Miguel Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990901/ https://www.ncbi.nlm.nih.gov/pubmed/33777024 http://dx.doi.org/10.3389/fimmu.2021.635371

Ejemplares similares

Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
por: Martinez, Miguel Angel
Publicado: (2021)

Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
por: Chatterjee, Bhaswati, et al.
Publicado: (2022)

Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022)

Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021)

Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19
por: Tang, Xianfang, et al.
Publicado: (2021)

Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing?
por: Khalil, Athar, et al.
Publicado: (2020)

Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021)

Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022)

Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities
por: Wehbe, Zena, et al.
Publicado: (2021)

Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Editorial: Repurposed Drugs as Immune-Modulators to Combat Infectious Diseases
por: Mishra, Bibhuti B., et al.
Publicado: (2022)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
por: Pizzorno, Andrés, et al.
Publicado: (2019)

Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
por: Adikusuma, Wirawan, et al.
Publicado: (2021)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
por: Borcherding, Nicholas, et al.
Publicado: (2020)

An Overview of Repurposed Drugs for Potential COVID-19 Treatment
por: Govender, Kamini, et al.
Publicado: (2022)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Network analytics for drug repurposing in COVID-19
por: Siminea, Nicoleta, et al.
Publicado: (2021)

Drug repurposing strategies for COVID-19
por: Senanayake, Suranga L
Publicado: (2020)

Perspective: repurposed drugs for COVID-19
por: Na-Bangchang, Kesara, et al.
Publicado: (2022)

Repurposing metabolic drugs for COVID-19
por: Bordon, Yvonne
Publicado: (2023)

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
por: Pizzorno, Andrés, et al.
Publicado: (2019)

Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
por: Devaux, Christian A., et al.
Publicado: (2021)

AI-powered drug repurposing for developing COVID-19 treatments
por: Liu, Zhichao, et al.
Publicado: (2022)

Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment
por: Zhang, Rongzhi, et al.
Publicado: (2022)

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
por: Raghav, Pawan Kumar, et al.
Publicado: (2023)

Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
por: Wang, Rui-Sheng, et al.
Publicado: (2023)

Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
por: Pires, David, et al.
Publicado: (2021)

Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
por: Mahmoud, Dina B., et al.
Publicado: (2020)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

Artificial intelligence in COVID-19 drug repurposing
por: Zhou, Yadi, et al.
Publicado: (2020)

Transcription-based drug repurposing for COVID-19
por: Killick, Richard, et al.
Publicado: (2020)

Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020)

Repurposing antimalarials and other drugs for COVID-19
por: Schlagenhauf, Patricia, et al.
Publicado: (2020)

Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma
por: Sulsenti, Roberta, et al.
Publicado: (2021)

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
por: Alam, Safaet, et al.
Publicado: (2021)

Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches
por: Batalha, Pedro N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s0di3d272641bp1pa5hqb1bvqq